NCT01812148View on ClinicalTrials.gov

Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Peritoneal Mesotheliomas
Interventions
PROCEDURE

Cytoreductive surgery and HIPEC

Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) with Oxaliplatin as chemotherapeutic agent

Trial Locations (1)

H1T 2M4

Maisonneuve Rosemont Hospital, Montreal

All Listed Sponsors
lead

Maisonneuve-Rosemont Hospital

OTHER

NCT01812148 - Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) | Biotech Hunter | Biotech Hunter